Zenith Epigenetics

Today 10/5/16 marks the completion of the fourth 28-day time period of the trial. So in theory, they should be starting on the 5th dosing level for the ZEN-3694 mCRPC trial. At some point soon, according to their June upate, they should be starting the ZEN-3694/enzalutamide combo trial.

BearDownAZ

Please login to post a reply
BearDownAZ
City
Madison, WI
Rank
President
Activity Points
6217
Rating
Your Rating
Date Joined
05/06/2015
Social Links
Private Message
Zenith Epigenetics
Symbol
ZZXY
Exchange
OTCBB
Shares
125,207,692
Industry
Technology & Medical
Create a Post